Clinical Trials

Ovarian Neoplasms, Recurrence, Thrombocytopenia

NCT00753545 2025-02-03

Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer

265 enrolled 25 charts 1 FDA

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

NCT03891576 2025-01-17

Newton

Phase 2 Terminated

83 enrolled

Anemia, Fallopian Tube Neoplasms, Neutropenia, Ovarian Neoplasms, Recurrence, Thrombocytopenia

NCT00516373 2024-02-22

A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)

Phase 1 Completed

98 enrolled

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

NCT03933813 2023-01-05

Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients

Phase 1/2 Terminated

9 enrolled

Carcinoma, Ovarian Epithelial, Iron Deficiencies, Anemia, Ovarian Neoplasms, Anemia, Iron-Deficiency

NCT01272817 2022-11-23

Mini-allo

BreastClassical hematologyDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcomaThoracic

36 enrolled

Anemia, Aplastic, Breast Neoplasms, Carcinoma, Renal Cell, Hemoglobinuria, Paroxysmal, Hodgkin Disease, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Ovarian Neoplasms, Sarcoma, Thymoma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04352439 2022-09-26

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Phase 4 Completed

19 enrolled 10 charts

Ovarian Neoplasms, Venous Thromboembolism

NCT02039388 2022-09-02

LUSTIC

701 enrolled

Fanconi Anemia, Complementation Group D1, Carcinoma, Ovarian Epithelial, Carcinoma in Situ, Neoplasms, Ovarian Neoplasms

NCT01953107 2021-05-12

Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.

Phase 4 Completed

200 enrolled

Anemia, Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

NCT04474951 2020-07-17

GALENO 1

Phase NA Unknown

60 enrolled

Anemia, Breast Neoplasms, Fatigue, Nausea, Ovarian Neoplasms

NCT00001806 2019-12-12

Methods in Education for Breast Cancer Genetics

Phase 3 Completed

170 enrolled

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

NCT00628251 2019-12-05

ICEBERG 3

97 enrolled 22 charts

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

NCT02418624 2019-01-16

REVIVAL

Phase 1 Completed

25 enrolled

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

NCT00494442 2018-08-01

ICEBERG 2

58 enrolled 13 charts

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

NCT00771810 2017-11-13

Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer

34 enrolled 19 charts

Cytopenia, Anemia, Lymphopenia, Neutropenia, Ovarian Neoplasms, Thrombocytopenia

NCT00419510 2016-08-17

Genetic Counseling in African American Women

204 enrolled

BreastClassical hematologyGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

NCT01325558 2016-07-15

A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

30 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Venous Thromboembolism

NCT01346761 2016-04-14

REACH

1,012 enrolled

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms, Genetic Predisposition to Disease

NCT01772979 2013-01-21

MITO15

Phase 2 Unknown

100 enrolled

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

NCT00165152 2012-08-09

Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing

150 enrolled

BreastClassical hematologyGastrointestinalGenitourinaryGynecologicLymphoidPlasma cellThoracic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

NCT00270166 2011-05-18

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

Phase 3 Completed

201 enrolled

Anemia, Breast Neoplasms, Esophageal Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT00121030 2007-12-24

Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy